β‑thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report

Wu,Liusong; Peng,Zhiyu; Lu,Sen; Tan,Mei; Rong,Ying; Tian,Runmei; Yang,Yuhang; Chen,Yan; Chen,Jindong

doi:10.3892/mmr.2017.7476

β‑thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report

Authors:
- Liusong Wu
- Zhiyu Peng
- Sen Lu
- Mei Tan
- Ying Rong
- Runmei Tian
- Yuhang Yang
- Yan Chen
- Jindong Chen
View Affiliations

Affiliations: Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China, Beijing Genomics Institute‑Shenzhen, Shenzhen, Guangdong 518000, P.R. China, Department of Urology, University of Rochester Medical Center, Rochester, NY 14642, USA
Published online on: September 12, 2017 https://doi.org/10.3892/mmr.2017.7476
Pages: 6552-6557
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, a rare familial case of severe thalassemia with compound spontaneous mutations is reported. A 2.5‑year‑old boy, who suffered from severe anemia with yellowish skin, enlarged liver and spleen, was provided with a blood transfusion every 20 days to maintain hemoglobin levels between 90 and 100 g/l. Sanger sequencing combined with reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and Gap‑PCR revealed that the proband was a carrier of 4 compound heterozygous mutations: Hemoglobin subunit β (HBB):IVS‑II‑654(C>T)β+; Southeast Asian‑type‑hereditary persistence of fetal hemoglobin (SEA‑HPFH); HBB:c316‑148G>T; hemoglobin subunit α2 (HBA2):c.46G>A. The father of the proband was identified as a carrier of the heterozygous SEA‑HPFH mutation, the mother was a carrier of compound heterozygous mutations of HBB:IVS‑II‑654(C>T) and HBA2:c.46G>A, and the elder sister was heterozygous for HBB:IVS‑II‑654(C>T)β+. Based on these genetic results, it was determined that the proband had both of heavy β‑thalassemia and α‑thalassemia. Upon human leukocyte antigen matching, bone marrow transplantation (BMT) was successfully performed on the proband by selecting his HLA‑compatible sister as a donor. Following treatment, the proband was revealed to only carry the IVS‑II‑654(C>T)β+ heterozygous mutation, and further regular blood transfusions have been avoided; BMT results remained normal at six months follow‑up.

View Figures

View References

1	Higgs DR, Engel JD and Stamatoyannopoulos G: Thalassaemia. Lancet. 379:373–383. 2012. View Article : Google Scholar : PubMed/NCBI
2	Muncie HL Jr and Campbell J: Alpha and beta thalassemia. Am Fam Physician. 80:339–344. 2009.PubMed/NCBI
3	Cai R, Li L, Liang X, Liu Z, Su L, Li W, Zhu Q, Mo Q, Pan L, Ouyang H, et al: Prevalence survey and molecular characterization of alpha and beta thalassemia in Liuzhou city of Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi. 23:281–285. 2002.(In Chinese). PubMed/NCBI
4	Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, et al: The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: Implications for the future health burden and population screening. J Clin Pathol. 57:517–522. 2004. View Article : Google Scholar : PubMed/NCBI
5	Zhang J, Zhu BS, He J, Zeng XH, Su J, Xu XH, Li SY, Chen H and Zhang YH: The spectrum of a- and b-thalassemia mutations in Yunnan Province of Southwestern China. Hemoglobin. 36:464–473. 2012. View Article : Google Scholar : PubMed/NCBI
6	Hu ZH, Liu YL, Zeng ZY, Zhang XL and Zhu QY: Beta-thalassemia majar caused by compound heterozygosity for +40 to −43(−AAAC), IVS-2-654 (C to T) and codon 41/42 (−TCTT). Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 25:418–420. 2008.(In Chinese). PubMed/NCBI
7	Babashah S, Jamali S, Mahdian R, Nosaeid MH, Karimipoor M, Alimohammadi R, Raeisi M, Maryami F, Masoudifar M and Zeinali S: Detection of unknown deletions in beta-globin gene cluster using relative quantitative PCR methods. Eur J Haematol. 83:261–269. 2009. View Article : Google Scholar : PubMed/NCBI
8	Fallah MS, Mahdian R, Aleyasin SA, Jamali S, Hayat-Nosaeid M, Karimipour M, Raeisi M and Zeinali S: Development of a quantitative real-time PCR assay for detection of unknown alpha-globin gene deletions. Blood Cells Mol Dis. 45:58–64. 2010. View Article : Google Scholar : PubMed/NCBI
9	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
10	Liu Z, Zhong X, Li Z and Xu X: Rapid detection of an HPFH deletion by PCR amplification with three primers bridging the breakpoint. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 16:41–43. 1999.(In Chinese). PubMed/NCBI
11	Chong SS, Boehm CD, Cutting GR and Higgs DR: Simplified multiplex-PCR diagnosis of common southeast asian deletional determinants of alpha-thalassemia. Clin Chem. 46:1692–1695. 2000.PubMed/NCBI
12	Giardine B, Borg J, Viennas E, Pavlidis C, Moradkhani K, Joly P, Bartsakoulia M, Riemer C, Miller W, Tzimas G, et al: Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 42(Database Issue): D1063–D1069. 2014. View Article : Google Scholar : PubMed/NCBI
13	Carlice-Dos-Reis T, Viana J, Moreira FC, Cardoso GL, Guerreiro J, Santos S and Ribeiro-Dos-Santos Â: Investigation of mutations in the HBB gene using the 1,000 genomes database. PLoS One. 12:e01746372017. View Article : Google Scholar : PubMed/NCBI
14	Long G and Zhang J: Hemoglobin & Hemoglobinopathies. Guangxi Science & Technology Press; Guangxi: pp. 233–235. 2003
15	Cao A and Galanello R: Beta-thalassemia. Genet Med. 12:61–76. 2010. View Article : Google Scholar : PubMed/NCBI
16	Mosca A, Paleari R, Leone D and Ivaldi G: The relevance of hemoglobin F measurement in the diagnosis of thalassemias and related hemoglobinopathies. Clin Biochem. 42:1797–1801. 2009. View Article : Google Scholar : PubMed/NCBI
17	Liu G and Sun S: The laboratory diagnosis of thelassemia: Selection and evaluation of tests and methods. Chin J Lab Med. 35:385–387. 2012.
18	Bollekens JA and Forget BG: Delta beta thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am. 5:399–422. 1991.PubMed/NCBI
19	Zhang J, He J, Zeng XH, Ge SJ, Huang Y, Su J, Ding XM, Yang JQ, Cao YJ, Chen H, et al: Genetic heterogeneity of the β-globin gene in various geographic populations of Yunnan in southwestern China. PLoS One. 10:e01229562015. View Article : Google Scholar : PubMed/NCBI
20	Huang SZ, Zeng FY, Ren ZR, Lu ZH, Rodgers GP, Schechter AN and Zeng YT: RNA transcripts of the beta-thalassaemia allele IVS-2-654 C->T: A small amount of normally processed beta-globin mRNA is still produced from the mutant gene. Br J Haematol. 88:541–546. 1994. View Article : Google Scholar : PubMed/NCBI
21	Changsri K, Akkarapathumwong V, Jamsai D, Winichagoon P and Fucharoen S: Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin. Int J Hematol. 83:229–237. 2006. View Article : Google Scholar : PubMed/NCBI
22	Zheng W, Liu Y, Chen D, Rong K, Ge Y, Gong C and Chen H: Complex interaction of Hb Q-Thailand and Hb E with alpha(0)-thalassemia and hereditary persistence of fetal hemoglobin in a Chinese family. Ann Hematol. 89:883–888. 2010. View Article : Google Scholar : PubMed/NCBI
23	Xiu X: The molecular basis of the δβ-thalassemia for HPFH and deletion seen in the Chinese. Chin J Med Genet. 15:315–317. 1998.
24	Bhardwaj U and McCabe ER: Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin. Mol Diagn. 9:151–156. 2005. View Article : Google Scholar : PubMed/NCBI
25	Xu XM, Li ZQ, Liu ZY, Zhong XL, Zhao YZ and Mo QH: Molecular characterization and PCR detection of a deletional HPFH: Application to rapid prenatal diagnosis for compound heterozygotes of this defect with beta-thalassemia in a Chinese family. Am J Hematol. 65:183–188. 2000. View Article : Google Scholar : PubMed/NCBI
26	Smiers FJ, Krishnamurti L and Lucarelli G: Hematopoietic stem cell transplantation for hemoglobinopathies: Current practice and emerging trends. Pediatr Clin North Am. 57:181–205. 2010. View Article : Google Scholar : PubMed/NCBI
27	Caocci G, La Nasa G, d'Aloja E, Vacca A, Piras E, Pintor M, Demontis R and Pisu S: Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients. BMC Med Ethics. 12:42011. View Article : Google Scholar : PubMed/NCBI
28	Valcárcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, Marks DI, McCarthy PL, Oudshoorn M, Petersdorf EW, et al: One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International blood and marrow transplant research results in the era of molecular HLA typing. Biol Blood Marrow Transplant. 17:640–648. 2011. View Article : Google Scholar : PubMed/NCBI